[The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice].
There are studying the symptoms of development catalepsy at new home preparation, which is having the butirophenone's derivative. There are shown that the time development and manifestation of catalepsy are depending from preparation's dose: 0.1 mg/kg-1.3 mg/kg (maximum) -10 mg/kg in intravenous introduction and 1.2 mg/kg-3.5 mg/kg (maximum)-40 mg/kg in intraperitoneal introduction.
Shapovalova
V O
VO
Mykhaĭlov
V S
VS
Shapovalov
V V
VV
D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D002375:Catalepsy / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D013997:Time Factors
D014150:Antipsychotic Agents; D006220:Haloperidol
Osoblyvosti rozvytku kataleptychnykh iavyshch pry diï novoho vitchyznianoho neĭroleptyka--pokhidnoho butyrofenonu v eksperymenti na myshakh.